Scout | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

The STRIPE program funds pre-clinical research exploring how radiopharmaceutical therapy (RPT) impacts cancer biology, focusing on normal tissue, tumor cells, and the tumor microenvironment. Successful projects will test hypotheses about RPT's dynamic effects on cancer processes, with the goal of informing new targeting strategies and RPT-based clinical trials.

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 18, 2024

Open for Submission: November 18, 2024

Submission Deadline: May 7, 2025

Application Window Closes: May 7, 2025

Keywords

radiopharmaceutical therapy

cancer biology

pre-clinical research

tumor microenvironment

normal tissue

RPT agents

targeting strategies

model systems

cancer processes

clinical trials

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers